{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:30:19Z","timestamp":1777159819839,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/aci.0000000000000062","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T17:04:39Z","timestamp":1398704679000},"page":"192-199","source":"Crossref","is-referenced-by-count":9,"title":["Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhood"],"prefix":"10.1097","volume":"14","author":[{"given":"D\u00e9sir\u00e9e","family":"Larenas-Linnemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Pfaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","article-title":"Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.","volume":"64","author":"Ait-Khaled","year":"2009","journal-title":"Allergy"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1398-9995.2009.02263.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper.","volume":"65","author":"Baiardini","year":"2010","journal-title":"Allergy"},{"key":"R3-5-20210128","first-page":"289","article-title":"Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials Immunol Allergy Clin North A","volume":"31","author":"Pfaar","year":"2011","journal-title":"m"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ACI.0b013e32835358b3","article-title":"Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.","volume":"12","author":"Calderon","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1398-9995.2010.02531.x","article-title":"Prospective validation of Allergy-Control-SCORE: a novel symptom-medication score for clinical trials.","volume":"66","author":"Hafner","year":"2011","journal-title":"Allergy"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2045-7022-2-17","article-title":"Prospective validation of the rhino conjunctivitis allergy-control-SCORE (RC-ACS).","volume":"2","author":"Hafner","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2222.2011.03700.x","article-title":"The Average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials.","volume":"41","author":"Grouin","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1398-9995.2010.02515.x","article-title":"A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis.","volume":"66","author":"Franzke","year":"2011","journal-title":"Allergy"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.aller.2009.09.002","article-title":"Health burden of co-morbid asthma and allergic rhinitis in West Indian children.","volume":"38","author":"Pinto Pereira","year":"2010","journal-title":"Allergol Immunopathol"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4104\/pcrj.2012.00036","article-title":"Management of co-morbid allergic rhinitis and asthma in a low and middle income healthcare setting.","volume":"21","author":"Yusuf","year":"2012","journal-title":"Primary Care Respir J"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2288-12-160","article-title":"Validity of information on atopic disease and other illness in young children reported by parents in a prospective birth cohort study.","volume":"12","author":"Vissing","year":"2012","journal-title":"BMC Med Res Method"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.","volume":"126","author":"Brozek","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 3","key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1097\/1939-4551-5-S3-S210","article-title":"Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.","volume":"5","author":"Valovirta","year":"2012","journal-title":"World Allergy Organ J"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2009.03.015","article-title":"Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.","volume":"123","author":"Baroody","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2045-7022-3-42","article-title":"The placebo effect in allergen-specific immunotherapy trials.","volume":"3","author":"Narkus","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.iac.2011.02.005","article-title":"Mechanisms of sublingual immunotherapy.","volume":"31","author":"Scadding","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1398-9995.2007.01416.x","article-title":"Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.","volume":"62","author":"Calderon","year":"2007","journal-title":"Allergy"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.","volume":"128","author":"Didier","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-7022-2-16","article-title":"Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time.","volume":"2","author":"Fonseca","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2222.2011.03734.x","article-title":"Validation of a self-questionnaire for assessing the control of allergic rhinitis.","volume":"41","author":"Demoly","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2009.11.063","article-title":"Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control.","volume":"104","author":"Schatz","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.2500\/ar.2013.4.0060","article-title":"Perceptual accuracy of upper airway compromise in children: clinical relevance and future directions for research.","volume":"4","author":"Koinis-Mitchell","year":"2013","journal-title":"Allergy Rhinol"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1399-3038.2012.01329.x","article-title":"The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis.","volume":"24","author":"Roder","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-7022-3-7","article-title":"Assessment of disease control in allergic rhinitis.","volume":"3","author":"Demoly","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaci.2012.07.053","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.","volume":"130","author":"Bousquet","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2007.03.034","article-title":"Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study.","volume":"120","author":"Walker","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2006.12.651","article-title":"Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.","volume":"119","author":"Roder","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(98)70380-X","article-title":"Measuring quality of life in children with rhinoconjunctivitis.","volume":"101","author":"Juniper","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1939-4551-6-5","article-title":"Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray.","volume":"6","author":"Meltzer","year":"2013","journal-title":"World Allergy Organ J"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2500\/ajra.2013.27.3923","article-title":"Randomized double-blind placebo-controlled crossover study of efficacy of pollen blocker cream for perennial allergic rhinitis.","volume":"27","author":"Li","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000343018","article-title":"Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA(2)LEN joint paper.","volume":"161","author":"Bousquet","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1398-9995.2011.02590.x","article-title":"How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.","volume":"66","author":"Bousquet","year":"2011","journal-title":"Allergy"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:41:15Z","timestamp":1636562475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201406000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000062","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}